Italy fines Novartis, Roche €182.5M for alleged collusion

The Italian Competition Authority has fined Novartis (NVS) €92M and Roche (RHHBY) €90.5M for forming a cartel to push doctors to prescribe their jointly marketed and more expensive Lucentis therapy to treat vision problems instead of Roche's Avastin, which is older and far cheaper.

The agency accused the companies of portraying Avastin as riskier than Lucentis in order to influence prescriptions.

Both firms said they would appeal.

Novartis and Roche could face further problems if the EU looks into the case and finds that the collusion extended beyond Italy.

From other sites
Comments (1)
  • User 19940311
    , contributor
    Comment (1) | Send Message
    They sell life saving drugs but are a Cancer for humanity .
    9 Mar 2014, 04:29 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs